Drug Profile
Smallpox vaccine - HK inno.N
Alternative Names: CJ-50300Latest Information Update: 30 Jun 2020
Price :
$50
*
At a glance
- Originator CJ Corporation; CJ HealthCare
- Developer CJ Corporation
- Class Antivirals; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Smallpox
Most Recent Events
- 18 Jun 2020 CJ HealthCare is now called HK inno.N
- 31 Dec 2011 CJ Corporation completes a phase III trial in Smallpox (prevention) in South Korea (NCT01317238)
- 02 Aug 2011 CJ Corporation completes enrolment in its phase III trial for Smallpox (prevention) in South Korea (NCT01317238)